COVID-19 vaccination and breakthrough infections in patients with cancer

BACKGROUND: Vaccination is an important preventive health measure to protect against symptomatic and severe COVID-19. Impaired immunity secondary to an underlying malignancy or recent receipt of antineoplastic systemic therapies can result in less robust antibody titers following vaccination and pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, A.L., Labaki, C., Hsu, C.-Y., Bakouny, Z., Balanchivadze, N., Berg, S.A., Blau, S., Daher, A., El Zarif, T., Friese, C.R., Griffiths, E.A., Hawley, J.E., Hayes-Lattin, B., Karivedu, V., Latif, T., Mavromatis, B.H., McKay, R.R., Nagaraj, G., Nguyen, R.H., Panagiotou, O.A., Portuguese, A.J., Puc, M., Santos Dutra, M., Schroeder, B.A., Thakkar, A., Wulff-Burchfield, E.M., Mishra, S., Farmakiotis, D., Shyr, Yu, Warner, J.L., Choueiri, T.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704021/
https://www.ncbi.nlm.nih.gov/pubmed/34958894
http://dx.doi.org/10.1016/j.annonc.2021.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704021/
https://www.ncbi.nlm.nih.gov/pubmed/34958894
http://dx.doi.org/10.1016/j.annonc.2021.12.006

Ejemplares similares